Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer-Reference-Cited by-同舟云学术

Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer

Published:2018-09 Issue: Volume:432 Page:251-259
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Kawaguchi Kei,Miyake Kentaro^ORCID,Han Qinghong,Li Shukuan,Tan Yuying,Igarashi Kentaro,Kiyuna Tasuku,Miyake Masuyo,Higuchi Takashi,Oshiro Hiromichi,Zhang Zhiying,Razmjooei Sahar,Wangsiricharoen Sintawat^ORCID,Bouvet Michael^ORCID,Singh Shree Ram^ORCID,Unno Michiaki,Hoffman Robert M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference101 articles.

1. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey;Hoffman;Expet Opin. Biol. Ther.,2015

2. The wayward methyl group and the cascade to cancer;Hoffman;Cell Cycle,2017

3. Elevated overall rates of transmethylation in cell lines from diverse human tumors;Stern;In Vitro – Rapid Commun. Cell Biol.,1984

4. The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence;Xu;Oncotarget,2017

5. Stealth cationic liposomes modified with anti-CAGE single-chain fragment variable deliver recombinant methioninase for gastric carcinoma therapy;Xin;J. Nanosci. Nanotechnol.,2013

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of methioninase for cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. Induction of the DNA-Repair Gene POLQ only in BRCA1-mutant Breast-Cancer Cells by Methionine Restriction;Cancer Genomics - Proteomics;2024-06-29

3. DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts;Anticancer Research;2024-05-31

4. Targeting methionine metabolism in cancer: opportunities and challenges;Trends in Pharmacological Sciences;2024-05

5. Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts;Anticancer Research;2024-02-29